THE OPPORTUNITY Are you a program leader ready to shape how AI-native engineering actually ships at scale? The Adobe engineering organization is rewriting how complex, ambiguous programs move from strategy to delivery, and is looking for
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
This role required to work remotely in part-time basis. Client Overview Our client is one of the worlds fastest-growing artificial intelligence companies, partnering with leading AI research laboratories and global enterprises to accelerate the development and